Invention Grant
- Patent Title: Uses for 4,17β-dihydroxyandrost-4-ene-3-one
-
Application No.: US14813715Application Date: 2015-07-30
-
Publication No.: US09610292B2Publication Date: 2017-04-04
- Inventor: Alexander Tobias Teichmann , Heinrich Wieland
- Applicant: MaBel GmbH
- Applicant Address: DE Erlangen
- Assignee: MaBel GmbH
- Current Assignee: MaBel GmbH
- Current Assignee Address: DE Erlangen
- Agency: Griffin and Szipl PC
- Priority: EP06009894 20060512
- Main IPC: A61K31/568
- IPC: A61K31/568 ; A61K45/06 ; A61K31/56
Abstract:
The present invention relates to novel uses of 4,17β-dihydroxyandrost-4-ene-3-one (hereinafter 4-hydroxytestosterone), to a process for their preparation, to pharmaceutical compositions containing them, and to the use of said compounds for the prophylaxis and/or treatment of breast cancer in mammals irrespective of the estrogen-receptor status of the tumor.
Public/Granted literature
- US20160030448A1 Uses for 4, 17ß-dihydroxyandrost-4-ene-3-one Public/Granted day:2016-02-04
Information query
